Cholesterol, Total
Code:8012
| Includes | Cholesterol, total |
|---|
Analysis details
Methodology
- Colorimetric / photometric method
Expected Turnaround Time
1 day
Special Instructions
- Fast for 12 hours before specimen collection
- Avoid physical exertion and emotional stress for 30 minutes prior to collection
- Do not smoke during the 30 minutes before collection
How to use
The Cholesterol, Total test (blood cholesterol, total chol) is used to gauge cardiovascular risk, to screen individuals without symptoms as part of lipid profiling, and to follow the response to dietary change and lipid‑lowering therapy. Clinicians commonly pair total cholesterol with other lipid measures for a more complete assessment of dyslipidemia and treatment effect.
Limitations
Cholesterol is a fundamental component of cellular membranes and serves as the precursor for steroid hormones and bile acids. Because it is not water soluble, it circulates bound within lipoproteins that differ by density and composition, primarily very‑low‑density lipoproteins (VLDL), low‑density lipoproteins (LDL), and high‑density lipoproteins (HDL). LDL‑C and VLDL‑C are considered atherogenic, whereas HDL‑C participates in reverse cholesterol transport. Total cholesterol represents the cumulative cholesterol content across all lipoprotein classes. Most circulating cholesterol is synthesized by the liver, with additional contributions from dietary intake, notably from meat and full‑fat dairy products. When genetic susceptibility and/or excessive dietary intake are present, plasma cholesterol can increase, fostering atherosclerotic plaque development, vascular stiffening, and greater risk of ischemic heart disease and stroke.
| Unit | mg/dL | ||||
|---|---|---|---|---|---|
| Reference interval |
| ||||
| Indications | Routine adult lipid screening starting at age 20, with testing at least every 5 years, Use within a lipid panel that includes LDL‑C, VLDL‑C, HDL‑C, triglycerides, and an atherogenic index, Tracking the effect of diet modification or lipid‑lowering pharmacotherapy, Cardiovascular risk appraisal when risk factors are present (tobacco use; men >45 years or women >55 years; hypertension ≥140/90 mm Hg; family history of premature atherosclerotic cardiovascular disease; coronary artery disease; prior myocardial infarction or stroke; diabetes mellitus; overweight/obesity; alcohol misuse; high intake of animal fats; low physical activity), Targeted screening in children 2–10 years with a family history of premature cardiovascular disease or hypercholesterolemia |
Possible Causes of Abnormal Results
Increased levels
- anabolic steroids
- androgens
- corticosteroids
- high intake of animal fats
- pregnancy
- prolonged fasting
- smoking
- upright posture at phlebotomy
Decreased levels
- allopurinol
- cholestyramine
- clofibrate
- colchicine
- diet high in polyunsaturated fatty acids
- erythromycin
- estrogens
- intense physical exercise
- supine posture at phlebotomy
Specimen Requirements
| Specimen | Serum |
|---|---|
| Container | Gold/Tiger Top (SST, Gel Separator) |
| Volume | 0.5 mL (min 0.2 mL) |
| Storage Instructions | Room temperature, Refrigerated, Frozen |